Author
Listed:
- Achille Noel Dongmo Teudjieu
(Yaoundé University Teaching Hospital, Cameroon)
- Achille Aurele Mbassi
(Yaounde Central Hospital, Cameroon)
- Emilia Lyonga
(University of Yaoundé I, Cameroon)
- William Abange Baiye
(University of Buea, Cameroon)
- Anicette Chafa Betbeui
(University of Yaoundé I, Cameroon)
- Michel Toukam
(University of Yaoundé I, Cameroon)
- Geogette Ekanga
(Yaoundé University Teaching Hospital, Cameroon)
- Raoul Ibrahim Assana
(Institut Universitaire et Stratégique de l’Estuaire)
- Christian Lavoisier Yimtchi Ngassa
(University of Buea, Cameroon)
- Hortense Gonsu Kamga
(Yaoundé University Teaching Hospital, Cameroon)
Abstract
Background: A febrile urinary tract infection in men should suggest acute prostatitis. Any infection of the male urinary tract has the potential to affect the prostate. Acute prostatitis happens when your prostate gland becomes suddenly inflamed. The objectives of our study were to determine the prevalence of urinary tract infections and the associated risk factors in men presenting chronic and/or acute prostatitis. Also, to identify the associated bacterial strains and finally to establish their antibiotic susceptibility profile. Materials and Method: We conducted a prospective and cross-sectional study. A total of 77 male participants were recruited, aged 24 years to 84 years at the Urology Department of the Yaounde Central Hospital that presented with clinical signs and symptoms of urinary tract infection from February to June 2021. Urine specimens were collected and analyzed at the Bacteriology laboratory of the Yaoundé University Teaching Hospital. Isolation and identification of bacteria were done using conventional methods. Antibiotic susceptibility testing and interpretation were performed according to CASFM 2021, V.1.0 April. The statistical analysis of our data was done using SPSS version 22.0 software. Results: The prevalence of urinary tract infection in our studied population was 15.58% (12/77). Among the 12 participants with urinary tract infection, we isolated and identified six (6) bacteria species; Escherichia coli 25% (3/12), Proteus vulgaris 25% (3/12), Citrobacter freundii 16.67% (2/12), Pseudomonas fluorescent 16.67% (2/12), Enterococcus spp. 8.33% (1/12) and Proteus penneri 8.33% (1/12) respectively. Antibiotic susceptibility testing revealed reduced susceptibility to 3rd generation cephalosporins (cefotaxime, ceftazidime, ceftriaxone). Beta-lactams showed very low activity on almost all the family of Enterobacteriaceae strains isolated. Flouroquinolones (ciprofloxacin, ofloxacin and nalidixic acid) showed a resistance of more than 50% on the majority of the species isolated. All the isolated Gram negative bacteria were multi-drug resistant. Patients with a history of urinary tract tumors, urinary catheters, and diabetes were the most exposed to urinary tract infection; 58.33% (7/12 patients), 50.00 % (6/12) and 41.66% (5/12 patients) respectively. Participants of age >55 years were those presenting the most with urinary tract infection. Conclusions: Overall, Enterobacteriaceae were primarily isolated from patients with prostatitis. Urological history such as urinary tract tumors, and Diabetes were significantly associated with UTI.
Suggested Citation
Achille Noel Dongmo Teudjieu & Achille Aurele Mbassi & Emilia Lyonga & William Abange Baiye & Anicette Chafa Betbeui & Michel Toukam & Geogette Ekanga & Raoul Ibrahim Assana & Christian Lavoisier Yimt, 2023.
"Bacterial Profile, Antibiotic Susceptibility Pattern and Associated Risk Factors of Urinary Tract Infection Among Patient Suffering from Chronic and/or Acute Prostatitis at the Yaoundé Central Hospital, Centre Cameroon,"
European Journal of Medical and Health Sciences, European Open Science, vol. 5(5), pages 122-128, September.
Handle:
RePEc:epw:ejmed0:v:5:y:2023:i:5:id:41903
DOI: 10.24018/ejmed.2023.5.5.1903
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:5:y:2023:i:5:id:41903. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.